Showing posts with label Drug Safety Physician. Show all posts
Showing posts with label Drug Safety Physician. Show all posts

Tuesday, 17 February 2015

Connection between immune system and Immune based therapy or biological therapy



The ultimate cancer immunotherapy agent should be capable to differentiate between cancer and normal cells like specificity, be effective sufficient to kill small or large numbers of tumor cells like sensitivity, and lastly be competent to prevent recurrence of the tumor like durability. Currently, tumor immunology and immune based therapy is one of the most exciting and rapidly growing fields. 

The immune system is generally divided into two primary components such as the innate immune response or system, and the extremely precise but more gradually developing adaptive or acquired immune response or system. Innate immunity is rapidly acting but typically not very specific and includes physicochemical barriers (eg, skin and mucosa), blood proteins such as complement, phagocytic cells (such as neutrophils, macrophages, dendritic cells, and natural killer cells), and cytokines, which synchronize and regulate the cells involved in innate immunity. Adaptive immunity is thought of as the acquired arm of immunity, which allows for exquisite specificity, an ability to remember the previous existence of the pathogen and differentiate self from non-self and, significantly, the ability to respond more vigorously on repeat exposure to the pathogen.
The thought that the immune system may actively prevent the development of neoplasia is termed as cancer immunosurveillance. There are several nonspecific tumor immune based therapy approaches ranging from biological response modifiers (BRM) to recombinant cytokines.
 
www.gapsos.com
Biological response modifiers are molecules that can modify the biological response of cells to changes in its external environment, which in the perspective of cancer immune based therapy, might easily extent specific and non specific immune based therapies.

A number of investigations using recombinant cytokines, growth factors, or hormones in various fashions for human and veterinary cancer patients have been reported up to now. Many have investigated the in vitro and/or in vivo effects of the soluble cytokine (for example interferons, IL 2, IL 12, IL 15 and liposome encapsulation of the cytokine (for example liposomal IL 2) or use a virus, cell, plasmid, liposome DNA complex, or other mechanism to express the cytokine (such as recombinant poxvirus expressing IL 2).

Similar to any type of anticancer treatment, immunotherapy appears to work best in a minimal residual disease setting, signifying its most appropriate use will be in an adjuvant setting with local tumor therapies such as surgery or radiation therapy.

Global Allied Pharmaceuticals (GAP) consist an expert team of oncologists and researchers. To know more information about immunotherapy related services, you can contact on www.gapsos.com.

Thursday, 29 January 2015

Cancer can be tough but there is something that can still break it.

Uterine cancer is one of the commonest gynecological cancers, especially in white Americans. It is the seventh most common disorder across the world.  It occurs most often in postmenopausal women (up to 80% of cases), about 5% diagnosed less than 40 years of age. According to the American Cancer Society (ACS), more than 52,500 newly cases are diagnosed, while more than 8,500 cases of deaths with uterine cancer that estimated in 2014. To increases survival rate of this cancer, researchers applied immunotherapy for the treatment of this cancer.

There is no effective screening programmed, but occasionally cervical smears containing endometrial cancer cells or double thickness endometrial ultrasonic thickness of 4mm or more indicates a need for endometrial sampling
www.gapsos.com
www.gapsos.com

The actual cause of this cancer is unknown. There can be no doubt that estrogen can alter the behavior of this tumour but there is still a question about estrogen as a primary causal agent. Estrogen secreting tumors of the ovary are associated with an increased incidence of endometrial carcinoma. Estrogen given alone as in postmenopausal Hormone Replacement Therapy (HRT).

Approximately 75% of cases of this cancer occur in the postmenopausal period when estrogen values are low and progesterone is absent. Null parity and polycystic ovary syndrome (PCOS) with defective progesterone synthesis carry an increased risk. After long term use of oral contraceptives (birth control pills) reduces the incidence of both endometrial and ovarian carcinomas.The usual presenting symptom of this cancer is postmenopausal bleeding which carries a 10% risk of associated malignancy in the absence of hormone replacement therapy. 

The treatment of uterine cancer with immunotherapy that involves Dentritic Cell immunotherapy, adoptive T cell therapy, and immune-modulator.  In dentritic cell immunotherapy, processed antigens have capability to enhance the potential of patient’s immune system to fight with specific cancer cells. Immature form of dentritic cells are loaded tumour antigens such as tumour lysate, which exist as mRNA. (Immatureforms of dentritic cells are able to capturedand processed antigens, after interaction with chemokine receptors and its ligands, this cell migrate to the lymph nodes). 

Global Allied Pharmaceuticals (GAP) has new technology to developed advanced treatment of uterine cancer on the basis of immune oncology and immunotherapy. GAP has a team of experts for conducting clinical trials for new immunotherapeutic cancer agents, which are used in immunotherapy.

For more information kindly visit us at www.gapsos.com

Thursday, 18 December 2014

Pharmacovigilance act as monitor of drug safety.

Pharmcovigilance is the pharmacological science and activities relating to the assessment, understanding, detection and prevention of adverse effects or any other drug related problem. Pharmacovigilance has a major role to improve public health and safety in relation to drugs and to contribute in the assessment of benefits, effectiveness and risk of drugs, encouraging their safe, rational and more effective use. It is also to promote education and clinical trials. Its effective communication to health professionals and the public. Before a drug launch into the market to reach the public on time and cost-efficient manner, it passes through all phases of clinical trials and the goal of company. 
 
www.gapsos.com
www.gapsos.com
Basic needs of pharmacovigilance relating to tests on animals are insufficient to predict human safety due to this reason limited number of patient are selected in clinical trials for limited duration of time. By the time of licensing exposure of less than 5000 human subjects to a drug allows only the common adverse drug event to be estimated. Information about serious adverse reactions is any untoward medical occurrence that any dose results in significant disability and death, chromic toxicity, use in special groups such as children and pregnant woman. Main steps under pharmacovigilance, includes identifying information about risk associated with drugs, preventing harm to patients and post marketing surveillance. An adverse drug reaction is a response to a medicine which is noxious and unintended, and which occurs at normal dose.

In National Pharmacovigilance program (NPP), the nationwide clinical trials programmed, sponsored and coordinated by the country’s central drug regulatory agency (Central Drug Standard Control Organization to establish and manage a data base of adverse drug reaction for making informed regulatory decisions regarding marketing authorization of drugs in India for ensuring safety of drugs). Functions of NPP is to monitor the adverse drug reactions of medicines, maintain contacts with international regulatory bodies working in pharmacovigilance and exchange information on drug safety, assess the regulatory information about drug safety, and provide information to end-users through adverse drug reaction news bulletins and seminars.

GAP has a team of experts for Pharmacovigilance and immune- Oncology. We serve our customers by creating a safety profile of the drug which helps in gathering information on time.
For more information contact us:  www.gapsos.com

Sunday, 14 December 2014

Drug detoxification:- a part of drug safety procedure



Drug detoxification is a gathering of therapies went for accomplishing acute drug intoxication and drug withdrawal. It is a part of drug safety process. Detoxification essentially intends to accumulate diminishing the physical belonging created by addictive materials. It is not simple to recuperate from medication fixation. It is an extreme long street regularly joined by bunches of unverifiable squares. An individual unequipped for surrendering a fixation to medications without anyone else's input will be elevated to embrace diverse steps to experience detoxification handle and get discharged from this condemnation. 
 
http://www.gapsos.com
www.gapsos.com
The essential point of medication detoxification is to annihilate the poisons accumulated in the body, which settle in the wake of utilizing medications. This is achieved through an arrangement of detoxification. On the off chance that the poisons are not appropriately disconnected and any medication filth remains, it will create addictive long haul longing to take tranquilize once more. In the event that any mental and physical indications or body responses are indicated to be delivered from the terrible activity of any by-result of the medication, which works like a ward one, it is called medication withdrawal. 
http://www.gapsos.com/immuno_oncology.php
www.gapsos.com/immuno_oncology.php

There are diverse indications which demonstrate drug withdrawal, for example, shaking, sweating, cerebral pains, yearnings, queasiness, stomach cramping, regurgitating, and looseness of the bowels, disarray, sleep deprivation, fomentation, tension, wretchedness or other chronic changes. The sorts and fierceness of withdrawal side effects varies essentially relying upon the way of medication or for to what extent medications are generally utilized. The consistency of medication utilize additionally has incredible impact on withdrawal signs. Presently a day's kin don't regularly utilize stand out medication rather a mixture of medications is utilized. Might it be liquor and prescribed medications/liquor consolidated with cocaine, precious stone meth, and heroin or now and again split cocaine. 

These courses don't cover all parts of medication habit, for example, mental parts of dependence, physical components, social variables and compound behavioral matters that are amalgamated with compulsion. 

A few sorts of medications like methadone, heroin and doctor prescribed prescriptions require a time of healing medication detoxification. There are a few sorts of activated toward oneself, psychosomatic reliance connected with these unsafe materials, and a phase of therapeutic adjustment is generally suggested. The fundamental steps of medication detoxification are assessment stage, adjustment stage and directing the patient into treatment. 

Drug detoxification is a more extended procedure. Then again, for a few medications, it may be quick and for others, it may be abate. It's exceedingly critical that patient ought to experience such process quickly, on the off chance that he demonstrates side effects or basic poisonous reactions. Principally, finish evacuation of medication fixings is conceivable yet legitimate consideration must be taken to maintain a strategic distance from any side responses.GAP is a growing pharmaceutical company to provide many services like SCP, ADC, immune-oncology etc. Visit us at www.gapsos.com/scp.php to know further about us and what services we provide.

Thursday, 18 September 2014

With Anticipation, Human Testing is important too.


Along history, all types of healers have tried their hardest to distinguish solutions for different sicknesses that beset us. This methodology began with the utilization of regular components in numerous types of behavior. A percentage of the best known medications and Drug Safety Physician found in the last couple of hundreds of years are focused around concentrates of such common components, either found intentionally or while searching for something totally diverse. 

The last case is called serendipity or serendipitous disclosure, which is not to be considered totally inadvertent; for sure, incredible identities like Shakespeare or Louis Pasteur have evenhandedly said that risk does not strike a chord when proper Risk management planning is possible. Penicillin, a prominent anti-infection, is a renowned sample of serendipity in the field of medications: one day in 1928 Alexander Fleming neglected to blanket a specimen of a few staphylococcus microbes, which was therefore polluted by blue-green mold (penicilliumnotatum). He happened to push the use of what he named penicillin as a valuable disinfectant, until it accomplished overall achievement in treating a huge scope of irresistible diseases. 

In contemporary pharmaceutics, be that as it may, such advances have been made that researchers can test a great many new mixes against a huge number of old or new 'targets'. A focus, in pharmaceutical dialect, is the atomic structure included in the pathology of a certain sickness; regularly, these structures are proteins that could be empowered or repressed by the activity of a freshly discovered medication. 

When a freshly discovered particle shows powerful effect then the next step is drug discovery. Further groups of experts work with the substance to focus its negative consequences for different parts of the body, its conduct in diverse situations, whether it would be most effective as a pill, a fluid, a gas and so on and the amount of it one ought to preferably take. After all these parameters are dead set, the proposed of Medical Affairs company for  medication is managed, under strict regulations - this is called preclinical examination. 

Regardless of the amount researchers can anticipate by utilizing complex reenactments or even exploratory creatures, no medication might be discharged available without human testing, formally known as clinical trials. There are four stages to clinical trials, beginning from small groups of people to large, over numerous years and in different, cross-mainland focuses. Some of the time the "focus" of the medication infers that the trials can just occur amid specific seasons, or that the quantity of persons suitable is truly constrained. Besides, few individuals ever consent to partake in such a trial, dreading the dangers or neglecting to see the potential vast scale profit. Visit www.gapsos.com.